{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T21:43:55Z","timestamp":1788558235329,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T00:00:00Z","timestamp":1652054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.ejps.2022.106205","type":"journal-article","created":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T11:51:36Z","timestamp":1652183496000},"page":"106205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Bactericidal activities and action mechanism of the novel antimicrobial peptide Hylin a1 and its analog peptides against Acinetobacter baumannii infection"],"prefix":"10.1016","volume":"175","author":[{"given":"Hee Joo","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Kyoung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunji","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoonkyung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2022.106205_bib0001","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.3390\/ph6121543","article-title":"Antimicrobial peptides","volume":"6","author":"BAHAR","year":"2013","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejps.2022.106205_bib0002","doi-asserted-by":"crossref","DOI":"10.1101\/pdb.prot073411","article-title":"Manual hematoxylin and eosin staining of mouse tissue sections","volume":"2014","author":"CARDIFF","year":"2014","journal-title":"Cold Spring Harb. Protoc."},{"key":"10.1016\/j.ejps.2022.106205_bib0003","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.peptides.2008.11.003","article-title":"Hylin a1, the first cytolytic peptide isolated from the arboreal South American frog Hypsiboas albopunctatus (\u201cspotted treefrog\u201d)","volume":"30","author":"CASTRO","year":"2009","journal-title":"Peptides"},{"key":"10.1016\/j.ejps.2022.106205_bib0004","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nrd1008","article-title":"Understanding biofilm resistance to antibacterial agents","volume":"2","author":"DAVIES","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejps.2022.106205_bib0005","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0304-4157(90)90006-X","article-title":"The actions of melittin on membranes","volume":"1031","author":"DEMPSEY","year":"1990","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.ejps.2022.106205_bib0006","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/nrmicro1789","article-title":"An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii","volume":"5","author":"DIJKSHOORN","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejps.2022.106205_bib0007","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.bbamem.2006.01.018","article-title":"Role of membrane lipids in the mechanism of bacterial species selective toxicity by two \u03b1\/\u03b2-antimicrobial peptides","volume":"1758","author":"EPAND","year":"2006","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.ejps.2022.106205_bib0008","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S1286-4579(02)01604-0","article-title":"Structure and function of lipopolysaccharides","volume":"4","author":"ERRIDGE","year":"2002","journal-title":"Microbes Infect."},{"key":"10.1016\/j.ejps.2022.106205_bib0009","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1399-3011.1990.tb00939.x","article-title":"Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids","volume":"35","author":"FIELDS","year":"1990","journal-title":"Int. J. Pept. Protein Res."},{"key":"10.1016\/j.ejps.2022.106205_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc8853","article-title":"Prevention of central venous catheter-related infection in the intensive care unit","volume":"14","author":"FRASCA","year":"2010","journal-title":"Critical Care"},{"key":"10.1016\/j.ejps.2022.106205_bib0011","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0966-842X(00)01823-0","article-title":"The role of cationic antimicrobial peptides in innate host defences","volume":"8","author":"HANCOCK","year":"2000","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ejps.2022.106205_bib0012","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/bip.22250","article-title":"Peptide design for antimicrobial and immunomodulatory applications","volume":"100","author":"HANEY","year":"2013","journal-title":"Pept. Sci. (Hoboken)"},{"key":"10.1016\/j.ejps.2022.106205_bib0013","first-page":"1","article-title":"Acute intraperitoneal infection with a hypervirulent Acinetobacter baumannii isolate in mice","volume":"9","author":"HARRIS","year":"2019","journal-title":"Scientific rep."},{"key":"10.1016\/j.ejps.2022.106205_bib0014","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/femsre\/fuv015","article-title":"Giving structure to the biofilm matrix: an overview of individual strategies and emerging common themes","volume":"39","author":"HOBLEY","year":"2015","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.ejps.2022.106205_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.00042-16","article-title":"Carbapenem-resistant Acinetobacter baumannii and Enterobacteriaceae in south and southeast Asia","volume":"30","author":"HSU","year":"2017","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejps.2022.106205_bib0016","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.mjafi.2014.04.011","article-title":"Antimicrobial resistance: a public health challenge","volume":"71","author":"JINDAL","year":"2015","journal-title":"Med. J. Armed Forces India"},{"key":"10.1016\/j.ejps.2022.106205_bib0017","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.3390\/ijms19103041","article-title":"Antibacterial and antibiofilm activity and mode of action of magainin 2 against drug-resistant Acinetobacter baumannii","volume":"19","author":"KIM","year":"2018","journal-title":"Int. J. Mol. Med. Sci."},{"key":"10.1016\/j.ejps.2022.106205_bib0018","doi-asserted-by":"crossref","first-page":"8648","DOI":"10.1021\/bi0004549","article-title":"Interactions of the novel antimicrobial peptide buforin 2 with lipid bilayers: proline as a translocation promoting factor","volume":"39","author":"KOBAYASHI","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejps.2022.106205_bib0019","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1136\/jcp.26.11.821","article-title":"The ortho-nitrophenol (ONPG) test and acid from lactose in Gram-negative genera","volume":"26","author":"LAPAGE","year":"1973","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.ejps.2022.106205_bib0020","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1128\/AAC.01998-15","article-title":"Antimicrobial peptide CMA3 derived from the CA-MA hybrid peptide: antibacterial and anti-inflammatory activities with low cytotoxicity and mechanism of action in Escherichia coli","volume":"60","author":"LEE","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2022.106205_bib0021","doi-asserted-by":"crossref","DOI":"10.1096\/fasebj.27.1_supplement.802.1","article-title":"Computational model for monitoring of the membrane potential with the fluorescent probe DiSC3 (5)","author":"LEMESHKO","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.ejps.2022.106205_bib0022","first-page":"9","article-title":"Preparation of artificial plasma membrane mimicking vesicles with lipid asymmetry","author":"LIN","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejps.2022.106205_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0005-2736(98)00035-2","article-title":"Voltage-dependent calcium influx in human sperm assessed by simultaneous optical detection of intracellular calcium and membrane potential","volume":"1372","author":"LINARES-HERN\u00e3NDEZ","year":"1998","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"10.1016\/j.ejps.2022.106205_bib0024","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1128\/AAC.26.4.546","article-title":"Use of the fluorescent probe 1-N-phenylnaphthylamine to study the interactions of aminoglycoside antibiotics with the outer membrane of Pseudomonas aeruginosa","volume":"26","author":"LOH","year":"1984","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2022.106205_bib0025","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3389\/fcimb.2016.00194","article-title":"Antimicrobial peptides: an emerging category of therapeutic agents","volume":"6","author":"MAHLAPUU","year":"2016","journal-title":"Front. Cell Infect. Microbiol."},{"key":"10.1016\/j.ejps.2022.106205_bib0026","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3389\/fmicb.2019.00539","article-title":"Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: a review","volume":"10","author":"MULANI","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejps.2022.106205_bib0027","series-title":"Antimicrobial resistance: global report on surveillance","author":"ORGANIZATION","year":"2014"},{"key":"10.1016\/j.ejps.2022.106205_bib0028","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1586\/eri.13.12","article-title":"Clinical relevance of the ESKAPE pathogens","volume":"11","author":"PENDLETON","year":"2013","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.ejps.2022.106205_bib0029","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ijmm.2010.04.005","article-title":"Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens","volume":"300","author":"PFEIFER","year":"2010","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.ejps.2022.106205_bib0030","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1023\/A:1018953309913","article-title":"Peptide stability in drug development. II. Effect of single amino acid substitution and glycosylation on peptide reactivity in human serum","volume":"10","author":"POWELL","year":"1993","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2022.106205_bib0031","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.4155\/tde.13.104","article-title":"Basics and recent advances in peptide and protein drug delivery","volume":"11","author":"BRUNO","year":"2013","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.ejps.2022.106205_bib0032","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.3389\/fmicb.2019.02866","article-title":"Mechanisms of action for antimicrobial peptides with antibacterial and antibiofilm functions","volume":"10","author":"RAHEEM","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejps.2022.106205_bib0033","series-title":"Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE","author":"RICE","year":"2008"},{"key":"10.1016\/j.ejps.2022.106205_bib0034","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s12602-017-9345-z","article-title":"Effects of hydrophobic amino acid substitutions on antimicrobial peptide behavior","volume":"10","author":"SAINT JEAN","year":"2018","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"10.1016\/j.ejps.2022.106205_bib0035","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1016\/j.febslet.2005.05.017","article-title":"Induced resistance to the antimicrobial peptide lactoferricin B in Staphylococcus aureus","volume":"579","author":"SAMUELSEN","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejps.2022.106205_bib0036","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0005-2736(99)00200-X","article-title":"Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by \u03b1-helical antimicrobial and cell non-selective membrane-lytic peptides","volume":"1462","author":"SHAI","year":"1999","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.ejps.2022.106205_bib0037","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.bbamem.2012.03.017","article-title":"Membrane and lipopolysaccharide interactions of C-terminal peptides from S1 peptidases","volume":"1818","author":"SINGH","year":"2012","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.ejps.2022.106205_bib0038","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1164\/rccm.201410-1894OE","article-title":"Novel approaches are needed to develop tomorrow's antibacterial therapies","volume":"191","author":"SPELLBERG","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejps.2022.106205_bib0039","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cocis.2010.05.006","article-title":"Interaction between amphiphilic peptides and phospholipid membranes","volume":"15","author":"STR\u00f8MSTEDT","year":"2010","journal-title":"Curr. Opin. Colloid Interface Sci."},{"key":"10.1016\/j.ejps.2022.106205_bib0040","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"TACCONELLI","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejps.2022.106205_bib0041","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s40265-014-0267-8","article-title":"Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacterbaumannii infections","volume":"74","author":"VIEHMAN","year":"2014","journal-title":"Drugs"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098722000902?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098722000902?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:01:34Z","timestamp":1760529694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098722000902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":41,"alternative-id":["S0928098722000902"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2022.106205","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bactericidal activities and action mechanism of the novel antimicrobial peptide Hylin a1 and its analog peptides against Acinetobacter baumannii infection","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2022.106205","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106205"}}